Evolent Health Inc (NYSE:EVH)
$ 23.28 0.39 (1.7%) Market Cap: 2.67 Bil Enterprise Value: 3.15 Bil PE Ratio: 0 PB Ratio: 2.55 GF Score: 73/100

Evolent Health Inc at Bank of America Global Healthcare Conference Transcript

May 09, 2023 / 03:40PM GMT
Release Date Price: $35.18 (+1.30%)
Allen Charles Lutz
BofA Securities, Research Division - Associate

Good morning. My name is Allen Lutz, health care analyst at BofA. We're pleased to have Evolent Health here. We have CFO, John Johnson; and Head of IR, Seth Frank.

Questions & Answers

Allen Charles Lutz
BofA Securities, Research Division - Associate

I guess, to level set here, Evolent has gone through quite an evolution over the past couple of years. John, can you do a quick walk-through of how the company has evolved and kind of where it's going from here?

John Paul Johnson
Evolent Health, Inc. - CFO

Yes. Thanks again for having us. If I had to have one word to describe this evolution that we've been on over the last couple of years. It will be focus. If you think of Evolent circa 2018, 2019, we had a lot of different products that we sold to a lot of different parties. And -- over the last several years, we've been on this journey of winnowing those down and identifying what are those products that create the most value, where we have

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot